Colgate-Palmolive Company — Q1 2023 Form 10-Q
Business context and reporting period. The filing covers the three months ended March 31, 2023, compared with Q1 2022. Colgate-Palmolive sells oral, personal and home care products across five geographic regions and pet nutrition products through Hill’s. Approximately two-thirds of sales came from outside the U.S.
Financial results and liquidity
| Metric | Q1 2023 | Q1 2022 |
|---|---|---|
| Net sales | $4.770 billion | $4.399 billion |
| Gross profit / margin | $2.712 billion / 56.9% | $2.572 billion / 58.5% |
| Operating profit / margin (GAAP) | $909 million / 19.1% | $860 million / 19.5% |
| Net income attributable to Colgate-Palmolive | $372 million | $559 million |
| Diluted EPS | $0.45 | $0.66 |
| Operating cash flow | $735 million | $386 million |
- Sales rose 8.5%; organic sales increased 10.0%. Net pricing contributed 12.0%, foreign exchange reduced growth by 3.5%, and reported volume was flat; acquisitions contributed 2.0% to volume.
- GAAP earnings included a $267 million ERISA litigation charge, $25 million of Fabuloso recall costs and $6 million of productivity-program charges. Excluding these items, management reported net income of $608 million versus $624 million and diluted EPS of $0.73 versus $0.74.
- Gross margin fell 160 basis points, chiefly due to higher raw and packaging costs, partly offset by pricing and cost savings. Adjusted operating margin was 19.7%, down from 21.0%.
- Cash from operations increased to $735 million, primarily from improved working capital; the cash flow statement also adds back the $267 million ERISA charge. Capital expenditures were $163 million. Cash and equivalents were $867 million at quarter-end.
- Total debt was $8.907 billion at March 31, 2023, versus $8.766 billion at year-end 2022. The company issued $1.5 billion of senior notes in March at fixed coupons of 4.6%–4.8%. Management said operating cash flow and debt issuance should cover foreseeable operating and recurring cash needs; the company was compliant with debt covenants.
- Current assets were $5.466 billion and current liabilities $4.441 billion. The company reported total equity of $425 million; Colgate-Palmolive Company shareholders’ equity was negative $6 million.
Material changes and segment performance
- Oral, Personal and Home Care sales increased 5.0% to $3.709 billion, with organic growth of 9.0%. Hill’s Pet Nutrition sales increased 21.5% to $1.061 billion, with organic growth of 14.0%.
- Hill’s operating profit declined 10% to $183 million; margin fell 620 basis points to 17.2%, reflecting high input costs and unfavorable mix, partly offset by pricing and cost savings.
- Regional operating profit improved in North America, Latin America and Africa/Eurasia, but declined in Europe and Asia Pacific. Europe’s operating profit fell 23%, with margin down 510 basis points.
- Advertising investment rose 14.4% to $579 million. Interest expense, net, increased to $54 million from $27 million, primarily due to higher rates and debt balances.
- Operating cash flow was higher than the prior year, while investing cash use increased to $264 million and financing cash use increased to $375 million. Financing included $500 million of debt principal payments, $1.495 billion of debt issuance and $390 million of dividends paid.
Outlook, risks and unusual items
- Management expects challenging conditions through 2023, including significantly higher raw and packaging costs, inflation, rising interest rates and foreign-exchange volatility. It is taking additional pricing and cost actions, but cautions that these may pressure demand, volumes and product mix. No specific full-year sales or EPS guidance is provided in the filing text.
- The 2022 Global Productivity Initiative is expected to be substantially complete by mid-2024, with cumulative pretax charges of $200–$240 million and projected annualized pretax savings of $90–$110 million once approved and implemented. Approximately 80%–90% of charges are expected to require cash expenditures.
- The $267 million ERISA charge followed an adverse appeals-court decision concerning pension benefit calculations. The company plans to seek U.S. Supreme Court review; it expects no immediate cash contribution to the retirement plan based on its current funded status.
- The voluntary Fabuloso recall affected selected U.S. and Canadian products; its $25 million operating-profit impact is not expected to be material in future periods.
- Management estimates reasonably possible losses across specified legal matters in excess of accrued liabilities at $0–approximately $250 million. Separate tax disputes include an estimated $145 million of tax and interest for U.S. years 2010–2018 that is not included in uncertain tax positions. The filing says ultimate outcomes are uncertain and could affect results or cash flows in a particular period.
- Other uncertainties include the war in Ukraine, residual COVID-19 disruptions, competitive and retailer pressures, and potential impairment risk for certain intangible assets. The company reported no material change to its previously disclosed risk factors.
Investor verification points
- Track whether pricing can offset input-cost inflation without further weakening volumes or shifting sales toward lower-margin products.
- Monitor gross and operating margins, especially Hill’s and Europe, and compare reported results with management’s adjusted measures.
- Verify cash conversion and working-capital trends, capital spending, debt levels and refinancing needs as interest costs rise.
- Follow the ERISA appeal and the potential range and timing of legal and tax exposures, including the disclosed $0–$250 million reasonably possible loss range.
- Assess progress, remaining charges and realized savings under the productivity initiative, and the financial effects of the Fabuloso recall.